Lantheus Medical Imaging has entered into an three-year agreement to provide its Definity and Ablavar to the members of Premier Purchasing Partners.
Definity Vial for (Perflutren Lipid Microsphere) Injectable Suspension is an ultrasound contrast agent which opacifies left ventricular chamber and improves the delineation of the left ventricular endocardial border cardiograms, thus treating patients with suboptimal echocardiograms.
Ablavar (gadofosveset trisodium) is a magnetic resonance angiography (MRA) blood pool imaging agent used to assess aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD).
Lantheus Medical Imaging president and CEO Don Kiepert said these products assist clinicians in the diagnosis of cardiovascular diseases and help answer critical clinical questions to make improved patient management decisions.